Julia Levy , Hong De Sa , Lindsey Loss , Mandy VanSandt , Rhusheet Patel , Merav Sendowski
{"title":"看见大白鲨:一例肝素诱发的血栓并发血小板增多症病例","authors":"Julia Levy , Hong De Sa , Lindsey Loss , Mandy VanSandt , Rhusheet Patel , Merav Sendowski","doi":"10.1016/j.rpth.2024.102587","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse response to heparin therapy, characterized by decreased platelet count and increased risk of thrombosis. HIT, without the tell-tale sign of thrombocytopenia, has rarely been described.</div></div><div><h3>Key Clinical Question</h3><div>Can HIT be diagnosed in the presence of thrombocytosis? What clinical clues and diagnostic tools facilitate accurate diagnosis in such cases?</div></div><div><h3>Clinical Approach</h3><div>We report a case of HIT with thrombocytosis in a young male who initially presented after traumatic knee dislocation. HIT was diagnosed clinically through the discovery of a white thrombus during a vascular surgery procedure and corroborated by a positive latex immunoturbidimetric immunoassay (HemosIL HIT-Ab <sub>(platelet-factor 4(PF4)-heparin)</sub>), a rapid immunoassay.</div></div><div><h3>Conclusion</h3><div>With its high sensitivity, specificity, and rapid results, the latex immunoturbidimetric immunoassay is a valuable diagnostic tool, even among patients with a seemingly low pretest probability. This case underscores the guidance imparted by Dr Andreas Greinacher: “[HIT] must be considered if thrombosis occurs or progresses despite effective heparinization even in the absence of thrombocytopenia.” Access to rapid and effective laboratory testing reduces the probability of diagnostic error.</div></div>","PeriodicalId":20893,"journal":{"name":"Research and Practice in Thrombosis and Haemostasis","volume":"8 7","pages":"Article 102587"},"PeriodicalIF":3.4000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Great white sighting: a case of heparin-induced thrombosis with thrombocytosis\",\"authors\":\"Julia Levy , Hong De Sa , Lindsey Loss , Mandy VanSandt , Rhusheet Patel , Merav Sendowski\",\"doi\":\"10.1016/j.rpth.2024.102587\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse response to heparin therapy, characterized by decreased platelet count and increased risk of thrombosis. HIT, without the tell-tale sign of thrombocytopenia, has rarely been described.</div></div><div><h3>Key Clinical Question</h3><div>Can HIT be diagnosed in the presence of thrombocytosis? What clinical clues and diagnostic tools facilitate accurate diagnosis in such cases?</div></div><div><h3>Clinical Approach</h3><div>We report a case of HIT with thrombocytosis in a young male who initially presented after traumatic knee dislocation. HIT was diagnosed clinically through the discovery of a white thrombus during a vascular surgery procedure and corroborated by a positive latex immunoturbidimetric immunoassay (HemosIL HIT-Ab <sub>(platelet-factor 4(PF4)-heparin)</sub>), a rapid immunoassay.</div></div><div><h3>Conclusion</h3><div>With its high sensitivity, specificity, and rapid results, the latex immunoturbidimetric immunoassay is a valuable diagnostic tool, even among patients with a seemingly low pretest probability. This case underscores the guidance imparted by Dr Andreas Greinacher: “[HIT] must be considered if thrombosis occurs or progresses despite effective heparinization even in the absence of thrombocytopenia.” Access to rapid and effective laboratory testing reduces the probability of diagnostic error.</div></div>\",\"PeriodicalId\":20893,\"journal\":{\"name\":\"Research and Practice in Thrombosis and Haemostasis\",\"volume\":\"8 7\",\"pages\":\"Article 102587\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Research and Practice in Thrombosis and Haemostasis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2475037924002826\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research and Practice in Thrombosis and Haemostasis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2475037924002826","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景肝素诱导的血小板减少症(HIT)是肝素治疗的一种免疫介导的不良反应,其特点是血小板计数减少和血栓形成风险增加。关键临床问题 在血小板减少的情况下能否诊断 HIT?哪些临床线索和诊断工具有助于在此类病例中做出准确诊断?临床方法我们报告了一例伴有血小板增多的 HIT 病例,患者为一名年轻男性,最初在外伤性膝关节脱位后就诊。HIT 的临床诊断是在血管外科手术中发现了白色血栓,并通过快速免疫测定乳胶免疫比浊法(HemosIL HIT-Ab(血小板因子 4(PF4)-肝素))的阳性结果得到证实。这个病例强调了 Andreas Greinacher 博士的指导:"即使没有血小板减少症,如果在有效肝素化疗后仍出现血栓或血栓进展,也必须考虑[HIT]"。快速有效的实验室检测可降低诊断错误的概率。
Great white sighting: a case of heparin-induced thrombosis with thrombocytosis
Background
Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse response to heparin therapy, characterized by decreased platelet count and increased risk of thrombosis. HIT, without the tell-tale sign of thrombocytopenia, has rarely been described.
Key Clinical Question
Can HIT be diagnosed in the presence of thrombocytosis? What clinical clues and diagnostic tools facilitate accurate diagnosis in such cases?
Clinical Approach
We report a case of HIT with thrombocytosis in a young male who initially presented after traumatic knee dislocation. HIT was diagnosed clinically through the discovery of a white thrombus during a vascular surgery procedure and corroborated by a positive latex immunoturbidimetric immunoassay (HemosIL HIT-Ab (platelet-factor 4(PF4)-heparin)), a rapid immunoassay.
Conclusion
With its high sensitivity, specificity, and rapid results, the latex immunoturbidimetric immunoassay is a valuable diagnostic tool, even among patients with a seemingly low pretest probability. This case underscores the guidance imparted by Dr Andreas Greinacher: “[HIT] must be considered if thrombosis occurs or progresses despite effective heparinization even in the absence of thrombocytopenia.” Access to rapid and effective laboratory testing reduces the probability of diagnostic error.